In a mouse model of NAFLD, liver-specific ABCA1 inactivation resulted in a decrease in plasma HDL levels and cholesterol efflux from hepatocytes [17]. The gene discussed is ABCA1; the disease is metabolic dysfunction-associated steatotic liver disease.